Upgrade to SI Premium - Free Trial

Cabaletta Bio (CABA)

2.60 -0.31 (10.65%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Form 8-K Cabaletta Bio, Inc. For: Sep 14 September 14, 2026 8:01 AM - SEC Filing TD Cowen Assumes Cabaletta Bio (CABA) at Buy August 22, 2026 7:55 AM - StreetInsider Form SCHEDULE 13G/A Cabaletta Bio, Inc. Filed by: Cormorant Asset Management, LP August 14, 2026 2:01 PM - SEC Filing Form SCHEDULE 13G/A Cabaletta Bio, Inc. Filed by: T. Rowe Price Investment Management, Inc. August 14, 2026 10:40 AM - SEC Filing Cabaletta Bio (CABA) PT Lowered to $3 at Wells Fargo August 14, 2026 8:51 AM - StreetInsider Form SCHEDULE 13G/A Cabaletta Bio, Inc. Filed by: Bain Capital Life Sciences Opportunities III, LP August 14, 2026 7:00 AM - SEC Filing TD Cowen: 'CABA appears well-positioned to scale commercially with minimal capital investment' August 13, 2026 10:32 AM - StreetInsider Form 10-Q Cabaletta Bio, Inc. For: Jun 30 August 13, 2026 7:35 AM - SEC Filing Form 8-K Cabaletta Bio, Inc. For: Aug 13 August 13, 2026 7:32 AM - SEC Filing Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update August 13, 2026 7:30 AM - StreetInsider Form SCHEDULE 13G/A Cabaletta Bio, Inc. Filed by: Adage Capital Management, L.P. August 12, 2026 12:06 PM - SEC Filing Form SCHEDULE 13G Cabaletta Bio, Inc. Filed by: NORGES BANK August 12, 2026 6:36 AM - SEC Filing Form SCHEDULE 13G Cabaletta Bio, Inc. Filed by: VANGUARD CAPITAL MANAGEMENT LLC July 31, 2026 9:55 AM - SEC Filing Form SCHEDULE 13G Cabaletta Bio, Inc. Filed by: BlackRock, Inc. July 27, 2026 4:27 PM - SEC Filing Form SCHEDULE 13G/A Cabaletta Bio, Inc. Filed by: MILLENNIUM MANAGEMENT LLC July 23, 2026 5:28 PM - SEC Filing Increasing unusual call option volume: GDS AM PGEN DFTX CTSH SWKS AIG BFLY OTLK EH CABA June 23, 2026 3:36 AM - StreetInsider Full Article List